Old Time Investor - Comments

Latest Comments
Protalix BioTherapeutics Pipeline Progress
5 years ago

My pleasure. What's more important than how prevalent the disease is, is how much money #Protalix can make on its new drug. It's competitor, #Sanofi ($SNY) makes $1 billion in revenue annually on their drug. Protalix's sounds like a more promising alternative. I'd definitely rate $PLX a buy.

In this article: PLX, SNY
Protalix BioTherapeutics Pipeline Progress
5 years ago

It's actually more common than you'd think. According to the article, Fabry disease occurs in one person per 40,000. But from my own research (ala Google), I know it affects about one in every 40,000 to 60,000 men worldwide. It can affect women as well but the prevalence is unknown.

In this article: PLX, SNY
Changing The Way We Fight Covid-19
5 years ago

Like these articles that really make one think and reexamine our preconceived notions.

This Is How It’s Supposed To Work
5 years ago

Are we sure they aren't? I had thought the US government were pursuing both.

In this article: XHB
Coronavirus: Let's Move On
5 years ago

Very interesting comment thread, thanks.

Avoid These 2 Stocks In July
5 years ago

Yes, timing is key.

In this article: SPG, RUTH
Empowering America
5 years ago

Well said Joseph.

Cannabis Central: Non-Penny Pot Stock Index Declined 1.3% On Friday - Here Are The Major Winners & Losers
5 years ago

What do you see happening in the cannabis market in the next 3 to 5 years?

In this article: NBEV, TLRY, PYX
Making Sense Of The Chaos
5 years ago

While I agree that people have the right to protest injustice, it is worth noting the chart in this article that puts things in perspective. It's also worth noting that far more blacks kill blacks, and more blacks kill whites, than white on black deaths. In fact far more whites are killed by police than black people.

I'm not saying people shouldn't protest, but all lives do matter.

151 to 160 of 197 comments
<<< 1 ... 14 15 16 17 18 ... 20 >>>

Following (0)

Followers (0)

Stocks I follow

General Stats

Article Comments

Received: 0
Created: 0